Log in

EMvision Medical Devices Stock Price, News & Analysis (ASX:EMV)

A$0.89
+0.01 (+1.14 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
A$0.89
Now: A$0.89
A$0.93
50-Day Range
A$0.37
MA: A$0.57
A$0.89
52-Week Range
A$0.28
Now: A$0.89
A$0.90
Volume59,184 shs
Average VolumeN/A
Market Capitalization$51.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
EMvision Medical Devices Limited focuses on developing and commercializing medical imaging devices using electromagnetic microwave imaging for diagnosing stroke and other medical applications in Europe and Australia. It intends to offer brain scanner, a portable clinical prototype that utilizes the EMvision technology to create three dimensional images of the human brain. EMvision Medical Devices Limited has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. The company was founded in 2017 and is based in Brisbane, Australia.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8667 5337

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.41 million
Cash FlowA$0.08 per share
Book ValueA$0.08 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$51.25 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMV News and Ratings via Email

Sign-up to receive the latest news and ratings for EMV and its competitors with MarketBeat's FREE daily newsletter.


EMvision Medical Devices (ASX:EMV) Frequently Asked Questions

What is EMvision Medical Devices' stock symbol?

EMvision Medical Devices trades on the ASX under the ticker symbol "EMV."

Has EMvision Medical Devices been receiving favorable news coverage?

News articles about EMV stock have been trending somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. EMvision Medical Devices earned a daily sentiment score of -1.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for EMvision Medical Devices.

Who are some of EMvision Medical Devices' key competitors?

Who are EMvision Medical Devices' key executives?

EMvision Medical Devices' management team includes the folowing people:
  • Mr. John Keep, Exec. Chairman
  • Dr. Ronald Peter Weinberger, Chief Exec. Officer
  • Ms. Emma Waldon, CFO & Company Sec. (Age 43)
  • Mr. Scott Kirkland, Exec. Director

What is EMvision Medical Devices' stock price today?

One share of EMV stock can currently be purchased for approximately A$0.89.

How big of a company is EMvision Medical Devices?

EMvision Medical Devices has a market capitalization of $51.25 million and generates $1.41 million in revenue each year. View Additional Information About EMvision Medical Devices.

What is EMvision Medical Devices' official website?

The official website for EMvision Medical Devices is http://www.emvision.com.au/.

How can I contact EMvision Medical Devices?

The company can be reached via phone at 61 2 8667 5337.


MarketBeat Community Rating for EMvision Medical Devices (ASX EMV)

Community Ranking:  4.5 out of 5 (star star star star half star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  100
MarketBeat's community ratings are surveys of what our community members think about EMvision Medical Devices and other stocks. Vote "Outperform" if you believe EMV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel